Questcor Pharmaceuticals (NASDAQ:QCOR)

CAPS Rating: 2 out of 5

A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system.

Recs

0
Player Avatar BuffettJunior1 (97.61) Submitted: 12/6/2012 11:12:47 PM : Underperform Start Price: $26.02 QCOR Score: -65.78

http://www.citronresearch.com/questcor-update-re-primethera/

Featured Broker Partners


Advertisement